Abstract
In mammals, one of the most pronounced consequences of viral infection is the induction of type I interferons, cytokines with potent antiviral activity. Schlafen (Slfn) genes are a subset of interferon-stimulated early response genes (ISGs) that are also induced directly by pathogens via the interferon regulatory factor 3 (IRF3) pathway1. However, many ISGs are of unknown or incompletely understood function. Here we show that human SLFN11 potently and specifically abrogates the production of retroviruses such as human immunodeficiency virus 1 (HIV-1). Our study revealed that SLFN11 has no effect on the early steps of the retroviral infection cycle, including reverse transcription, integration and transcription. Rather, SLFN11 acts at the late stage of virus production by selectively inhibiting the expression of viral proteins in a codon-usage-dependent manner. We further find that SLFN11 binds transfer RNA, and counteracts changes in the tRNA pool elicited by the presence of HIV. Our studies identified a novel antiviral mechanism within the innate immune response, in which SLFN11 selectively inhibits viral protein synthesis in HIV-infected cells by means of codon-bias discrimination.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sohn, W. J. et al. Novel transcriptional regulation of the schlafen-2 gene in macrophages in response to TLR-triggered stimulation. Mol. Immunol. 44, 3273–3282 (2007)
Yoneyama, M. et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175, 2851–2858 (2005)
Schwarz, D. A., Katayama, C. D. & Hedrick, S. M. Schlafen, a new family of growth regulatory genes that affect thymocyte development. Immunity 9, 657–668 (1998)
Geserick, P., Kaiser, F., Klemm, U., Kaufmann, S. H. & Zerrahn, J. Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif. Int. Immunol. 16, 1535–1548 (2004)
Berger, M. et al. An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence. Nature Immunol. 11, 335–343 (2010)
Fritz, C. C. & Green, M. R. HIV Rev uses a conserved cellular protein export pathway for the nucleocytoplasmic transport of viral RNAs. Curr. Biol. 6, 848–854 (1996)
Fischer, U., Huber, J., Boelens, W. C., Mattaj, I. W. & Luehrmann, R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82, 475–483 (1995)
Malim, M. H., Hauber, J., Le, S. Y., Maizel, J. V. & Cullen, B. R. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338, 254–257 (1989)
Van Damme, N. et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245–252 (2008)
Neil, S. J., Zang, T. & Bieniasz, P. D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425–430 (2008)
Ganser-Pornillos, B. K., Yeager, M. & Sundquist, W. I. The structural biology of HIV assembly. Curr. Opin. Struct. Biol. 18, 203–217 (2008)
Coleman, J. R. et al. Virus attenuation by genome-scale changes in codon pair bias. Science 320, 1784–1787 (2008)
Zhou, T., Gu, W., Ma, J., Sun, X. & Lu, Z. Analysis of synonymous codon usage in H5N1 virus and other influenza A viruses. Biosystems 81, 77–86 (2005)
Meintjes, P. L. & Rodrigo, A. G. Evolution of relative synonymous codon usage in human immunodeficiency virus type-1. J. Bioinform. Comput. Biol. 3, 157–168 (2005)
Frelin, L. et al. Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene. Gene Ther. 11, 522–533 (2004)
Forsberg, R. & Christiansen, F. B. A codon-based model of host-specific selection in parasites, with an application to the influenza A virus. Mol. Biol. Evol. 20, 1252–1259 (2003)
Plotkin, J. B. & Dushoff, J. Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc. Natl Acad. Sci. USA 100, 7152–7157 (2003)
Grantham, P. & Perrin, P. AIDS virus and HTLV-I differ in codon choices. Nature 319, 727–728 (1986)
Wong, E. H. M., Smith, D. K., Rabadan, R., Peiris, M. & Poon, L. L. M. Codon usage bias and the evolution of influenza A viruses. Codon usage biases of influenza virus. BMC Evol. Biol. 10, 253 (2010)
van Weringh, A. et al. HIV-1 modulates the tRNA pool to improve translation efficiency. Mol. Biol. Evol. 28, 1827–1834 (2011)
Kofman, A. et al. HIV-1 gag expression is quantitatively dependent on the ratio of native and optimized codons. Tsitologiia 45, 86–93 (2003)
Haas, J., Park, E. C. & Seed, B. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol. 6, 315–324 (1996)
Berkhout, B. & van Hemert, F. J. The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins. Nucleic Acids Res. 22, 1705–1711 (1994)
Kypr, J. & Mrazek, J. Unusual codon usage of HIV. Nature 327, 20 (1987)
Pavon-Eternod, M. et al. tRNA over-expression in breast cancer and functional consequences. Nucleic Acids Res. 37, 7268–7280 (2009)
Dittmar, K. A., Mobley, E. M., Radek, A. J. & Pan, T. Exploring the regulation of tRNA distribution on the genomic scale. J. Mol. Biol. 337, 31–47 (2004)
Coccia, E. M., Krust, B. & Hovanessian, A. G. Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment. J. Biol. Chem. 269, 23087–23094 (1994)
Connor, R. I., Chen, B. K., Choe, S. & Landau, N. R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206, 935–944 (1995)
Acknowledgements
We thank D. Smith for help with the HIV replication studies; M. Wood for performing the electron microscope analysis; D. Xu and D.-Y. Song for technical assistance; and J. Young, J. Guatelli, D. Smith, M. Kaul and S. Chanda for discussion. This work was supported in part by NIH AI81019 and AI074967 to M.D.W., NIH P01AI090935, R01GM101982 and R21AI088490 to M.D., and by resources from the UCSD Center for AIDS Research, NIH P30AI36214, and the HINT Program, NIH P01AI090935. The authors declare no competing financial interests.
Author information
Authors and Affiliations
Contributions
M.L., M.D.W., T.P. and M.D. planned the experiments; M.L., E.K., X.G., M.P.-E., K.L., H.S., T.E.J. and S.L. conducted the experiments; M.L., T.P., M.D.W. and M.D. analysed the data; and M.L. and M.D. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Figures
This file contains Supplementary Figures 1-7. (PDF 1925 kb)
Rights and permissions
About this article
Cite this article
Li, M., Kao, E., Gao, X. et al. Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature 491, 125–128 (2012). https://doi.org/10.1038/nature11433
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature11433
This article is cited by
-
Structural basis of MALAT1 RNA maturation and mascRNA biogenesis
Nature Structural & Molecular Biology (2024)
-
SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer
Journal of Ovarian Research (2023)
-
Modulation of SLFN11 induces changes in DNA Damage response in breast cancer
Cancer Cell International (2023)
-
Velcrin-induced selective cleavage of tRNALeu(TAA) by SLFN12 causes cancer cell death
Nature Chemical Biology (2023)
-
Codon optimality has minimal effect on determining translation efficiency in mycobacterium tuberculosis
Scientific Reports (2023)